Anti-diabetic medications and the risk of dementia

抗糖尿病药物和痴呆风险

• 批准号: 458305
• 负责人: Wu Che-Yuan
• 金额: $ 7.65万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-11-01 至 2024-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458305&lang=en
• 关键词: Aging; Anti-Diabetic Medications; Dementia; Diabetes Mellitus; Dipeptidyl Peptidase-4 (Dpp4) Inhibitor; Epidemiology; Sodium-Glucose Cotransporter-2 (Sglt2) Inhibitor; Stroke; Survival Analysis

Dementia is a major challenge for individuals, families, and the health care system. It is frustrating that effective treatment options are lacking. This necessitates the development of effective preventative strategies. Diabetes increases the risk of dem

痴呆症是个人、家庭和医疗保健系统面临的重大挑战。令人沮丧的是缺乏有效的治疗方案。这需要制定有效的预防策略。糖尿病会增加糖尿病的风险